ALKS
Alkermes Inc. plc
stockNASDAQ
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes' website at www.alkermes.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 40.15 | 2026-09-28 | +4.00% | 2.624 |
| 1M | 46.10 | 2026-09-04 | -9.43% | 1.308 |
| 3M | 55.14 | 2026-07-06 | -24.27% | 0.876 |
| 6M | 34.08 | 2026-04-06 | +22.52% | 0.433 |
| 1Y | 31.06 | 2025-10-03 | +34.43% | 0.801 |
| 2Y | 28.97 | 2024-10-04 | +44.13% | — |
| 5Y | 30.52 | 2021-10-04 | +36.81% | 0.601 |
Alkermes Inc. plc (NASDAQ:ALKS) stock price today is $41.76, and today's volume is 2,423,456. ALKS is up 2.997% today. The 30 day average volume is 2.01M. ALKS market cap is $7.00B with 167.76M shares outstanding.